Literature DB >> 21252286

Global microRNA analysis of the NCI-60 cancer cell panel.

Rolf Søkilde1, Bogumil Kaczkowski, Agnieszka Podolska, Susanna Cirera, Jan Gorodkin, Søren Møller, Thomas Litman.   

Abstract

MicroRNAs (miRNA) are a group of short noncoding RNAs that regulate gene expression at the posttranscriptional level. They are involved in many biological processes, including development, differentiation, apoptosis, and carcinogenesis. Because miRNAs may play a role in the initiation and progression of cancer, they comprise a novel class of promising diagnostic and prognostic molecular markers and potential drug targets. By applying an LNA-enhanced microarray platform, we studied the expression profiles of 955 miRNAs in the NCI-60 cancer cell lines and identified tissue- and cell-type-specific miRNA patterns by unsupervised hierarchical clustering and statistical analysis. A comparison of our data to three previously published miRNA expression studies on the NCI-60 panel showed a remarkably high correlation between the different technical platforms. In addition, the current work contributes expression data for 369 miRNAs that have not previously been profiled. Finally, by matching drug sensitivity data for the NCI-60 cells to their miRNA expression profiles, we found numerous drug-miRNAs pairs, for which the miRNA expression and drug sensitivity profiles were highly correlated and thus represent potential candidates for further investigation of drug resistance and sensitivity mechanisms. ©2011 AACR.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21252286     DOI: 10.1158/1535-7163.MCT-10-0605

Source DB:  PubMed          Journal:  Mol Cancer Ther        ISSN: 1535-7163            Impact factor:   6.261


  44 in total

1.  MicroRNA biogenesis and cellular proliferation.

Authors:  Divya Lenkala; Eric R Gamazon; Bonnie LaCroix; Hae Kyung Im; R Stephanie Huang
Journal:  Transl Res       Date:  2015-02-07       Impact factor: 7.012

2.  A ZEB1-miR-375-YAP1 pathway regulates epithelial plasticity in prostate cancer.

Authors:  L A Selth; R Das; S L Townley; I Coutinho; A R Hanson; M M Centenera; N Stylianou; K Sweeney; C Soekmadji; L Jovanovic; C C Nelson; A Zoubeidi; L M Butler; G J Goodall; B G Hollier; P A Gregory; W D Tilley
Journal:  Oncogene       Date:  2016-06-06       Impact factor: 9.867

3.  Differential expression of miR-139, miR-486 and miR-21 in breast cancer patients sub-classified according to lymph node status.

Authors:  Lene Rask; Eva Balslev; Rolf Søkilde; Estrid Høgdall; Henrik Flyger; Jens Eriksen; Thomas Litman
Journal:  Cell Oncol (Dordr)       Date:  2014-07-16       Impact factor: 6.730

4.  Dielectrophoresis has broad applicability to marker-free isolation of tumor cells from blood by microfluidic systems.

Authors:  Sangjo Shim; Katherine Stemke-Hale; Jamileh Noshari; Frederick F Becker; Peter R C Gascoyne
Journal:  Biomicrofluidics       Date:  2013-01-16       Impact factor: 2.800

5.  Small Cell Lung Cancer Screen of Oncology Drugs, Investigational Agents, and Gene and microRNA Expression.

Authors:  Eric Polley; Mark Kunkel; David Evans; Thomas Silvers; Rene Delosh; Julie Laudeman; Chad Ogle; Russell Reinhart; Michael Selby; John Connelly; Erik Harris; Nicole Fer; Dmitriy Sonkin; Gurmeet Kaur; Anne Monks; Shakun Malik; Joel Morris; Beverly A Teicher
Journal:  J Natl Cancer Inst       Date:  2016-05-31       Impact factor: 13.506

6.  Systematic integration of molecular profiles identifies miR-22 as a regulator of lipid and folate metabolism in breast cancer cells.

Authors:  C Koufaris; G N Valbuena; Y Pomyen; G D Tredwell; E Nevedomskaya; C-He Lau; T Yang; A Benito; J K Ellis; H C Keun
Journal:  Oncogene       Date:  2015-10-19       Impact factor: 9.867

7.  Inferring condition-specific miRNA activity from matched miRNA and mRNA expression data.

Authors:  Junpeng Zhang; Thuc Duy Le; Lin Liu; Bing Liu; Jianfeng He; Gregory J Goodall; Jiuyong Li
Journal:  Bioinformatics       Date:  2014-07-23       Impact factor: 6.937

8.  Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL).

Authors:  Ulrik Ralfkiaer; Peter H Hagedorn; Nannie Bangsgaard; Marianne B Løvendorf; Charlotte B Ahler; Lars Svensson; Katharina L Kopp; Marie T Vennegaard; Britt Lauenborg; John R Zibert; Thorbjørn Krejsgaard; Charlotte M Bonefeld; Rolf Søkilde; Lise M Gjerdrum; Tord Labuda; Anne-Merete Mathiesen; Kirsten Grønbæk; Mariusz A Wasik; Malgorzata Sokolowska-Wojdylo; Catherine Queille-Roussel; Robert Gniadecki; Elisabeth Ralfkiaer; Carsten Geisler; Thomas Litman; Anders Woetmann; Christian Glue; Mads A Røpke; Lone Skov; Niels Odum
Journal:  Blood       Date:  2011-08-24       Impact factor: 22.113

9.  Mapping posttranscriptional regulation of the human glycome uncovers microRNA defining the glycocode.

Authors:  Praveen Agrawal; Tomasz Kurcon; Kanoelani T Pilobello; John F Rakus; Sujeethraj Koppolu; Zhongyin Liu; Bianca S Batista; William S Eng; Ku-Lung Hsu; Yaxuan Liang; Lara K Mahal
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-03       Impact factor: 11.205

10.  Correlations between the dielectric properties and exterior morphology of cells revealed by dielectrophoretic field-flow fractionation.

Authors:  Peter R C Gascoyne; Sangjo Shim; Jamileh Noshari; Frederick F Becker; Katherine Stemke-Hale
Journal:  Electrophoresis       Date:  2013-04       Impact factor: 3.535

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.